U.S. flag

An official website of the United States government

NM_006516.4(SLC2A1):c.1198C>T (p.Arg400Cys) AND GLUT1 deficiency syndrome 1, autosomal recessive

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 22, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000463311.11

Allele description [Variation Report for NM_006516.4(SLC2A1):c.1198C>T (p.Arg400Cys)]

NM_006516.4(SLC2A1):c.1198C>T (p.Arg400Cys)

Gene:
SLC2A1:solute carrier family 2 member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p34.2
Genomic location:
Preferred name:
NM_006516.4(SLC2A1):c.1198C>T (p.Arg400Cys)
Other names:
p.R400C:CGT>TGT
HGVS:
  • NC_000001.11:g.42927685G>A
  • NG_008232.1:g.36492C>T
  • NM_006516.4:c.1198C>TMANE SELECT
  • NP_006507.2:p.Arg400Cys
  • LRG_1132:g.36492C>T
  • NC_000001.10:g.43393356G>A
  • NM_006516.2:c.1198C>T
Protein change:
R400C
Links:
dbSNP: rs796053263
NCBI 1000 Genomes Browser:
rs796053263
Molecular consequence:
  • NM_006516.4:c.1198C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
GLUT1 deficiency syndrome 1, autosomal recessive
Identifiers:
MedGen: C3149117

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000545832Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 22, 2023)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Allelic variations of glut-1 deficiency syndrome: the chinese experience.

Liu Y, Bao X, Wang D, Fu N, Zhang X, Cao G, Song F, Wang S, Zhang Y, Qin J, Yang H, Engelstad K, De Vivo DC, Wu X.

Pediatr Neurol. 2012 Jul;47(1):30-4. doi: 10.1016/j.pediatrneurol.2012.04.010.

PubMed [citation]
PMID:
22704013

From splitting GLUT1 deficiency syndromes to overlapping phenotypes.

Hully M, Vuillaumier-Barrot S, Le Bizec C, Boddaert N, Kaminska A, Lascelles K, de Lonlay P, Cances C, des Portes V, Roubertie A, Doummar D, LeBihannic A, Degos B, de Saint Martin A, Flori E, Pedespan JM, Goldenberg A, Vanhulle C, Bekri S, Roubergue A, Heron B, Cournelle MA, et al.

Eur J Med Genet. 2015 Sep;58(9):443-54. doi: 10.1016/j.ejmg.2015.06.007. Epub 2015 Jul 17.

PubMed [citation]
PMID:
26193382
See all PubMed Citations (7)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000545832.9

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 400 of the SLC2A1 protein (p.Arg400Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with GLUT1-deficiency syndrome (PMID: 22704013, 26193382, 28018440). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 207212). Advanced modeling performed at Invitae incorporating data from internal and/or published experimental studies (Invitae) indicates that this missense variant is expected to disrupt SLC2A1 function with a positive predictive value of 95%. This variant disrupts the p.Arg400 amino acid residue in SLC2A1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 21555602, 22976442, 25487684). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024